KaliVir Immunotherapeutics, a biotech developing oncolytic viral immunotherapy programs, has unveiled its state-of-the-art GMP cleanroom facility to manufacture its pipeline of oncolytic viruses. KaliVir has already executed the inaugural manufacturing run for its lead clinical candidate, VET3-TGI. KaliVir’s GMP manufacturing facility includes a cleanroom spanning over 1,000 square feet. The facility is equipped with the iCellis 500 bioreactor, hyperstack, filtration and chromatography capabi...